RE:Another laughable quarter . 1.1m in revenue, loss 39 Mil ..
More "expected, anticipated" nonsense language .....Are you going to resubmit it or NOT ......Also sounds to me like they have not even met with the FDA yet but are "expecting" to resubmit.....They have 3 months so its possible but I wouldn't babnk on it. Gawd ...
"We are looking forward to our expected resubmission, in the first half of 2020, of a Biological License Application ("BLA") with the United States Food and Drug Administration ("FDA") for Ryplazim® (plasminogen) for the treatment of patients with congenital plasminogen deficiency, and working with the FDA to review our anticipated resubmission during 2020," continued Mr. Galbraith. "Our first product approval from the FDA, if received, would be a historic event for Liminal BioSciences and our shareholders who have supported the Company's efforts to make this potential treatment available to patients in the United States, and eventually other countries."